278 related articles for article (PubMed ID: 35792918)
21. Genetic and Structural Brain Correlates of Cognitive Subtypes Across Youth at Family Risk for Schizophrenia and Bipolar Disorder.
Valli I; De la Serna E; Segura AG; Pariente JC; Calvet-Mirabent A; Borras R; Ilzarbe D; Moreno D; Martín-Martínez N; Baeza I; Rosa-Justicia M; Garcia-Rizo C; Díaz-Caneja CM; Crossley NA; Young AH; Vieta E; Mas S; Castro-Fornieles J; Sugranyes G
J Am Acad Child Adolesc Psychiatry; 2023 Jan; 62(1):74-83. PubMed ID: 35710081
[TBL] [Abstract][Full Text] [Related]
22. White and gray matter alterations in bipolar I and bipolar II disorder subtypes compared with healthy controls - exploring associations with disease course and polygenic risk.
Thiel K; Lemke H; Winter A; Flinkenflügel K; Waltemate L; Bonnekoh L; Grotegerd D; Dohm K; Hahn T; Förster K; Kanske P; Repple J; Opel N; Redlich R; David F; Forstner AJ; Stein F; Brosch K; Thomas-Odenthal F; Usemann P; Teutenberg L; Straube B; Alexander N; Jamalabadi H; Jansen A; Witt SH; Andlauer TFM; Pfennig A; Bauer M; Nenadić I; Kircher T; Meinert S; Dannlowski U
Neuropsychopharmacology; 2024 Apr; 49(5):814-823. PubMed ID: 38332015
[TBL] [Abstract][Full Text] [Related]
23. Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies.
Wang X; Tian F; Wang S; Cheng B; Qiu L; He M; Wang H; Duan M; Dai J; Jia Z
Hum Brain Mapp; 2018 Dec; 39(12):4707-4723. PubMed ID: 30096212
[TBL] [Abstract][Full Text] [Related]
24. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
25. Brain morphology does not clearly map to cognition in individuals on the bipolar-schizophrenia-spectrum: a cross-diagnostic study of cognitive subgroups.
Karantonis JA; Rossell SL; Carruthers SP; Sumner P; Hughes M; Green MJ; Pantelis C; Burdick KE; Cropley V; Van Rheenen TE
J Affect Disord; 2021 Feb; 281():776-785. PubMed ID: 33246649
[TBL] [Abstract][Full Text] [Related]
26. Shared and distinct structural brain alterations and cognitive features in drug-naïve schizophrenia and bipolar disorder.
Zhang W; Du JL; Fang XY; Ni LY; Zhu YY; Yan W; Lu SP; Zhang RR; Xie SP
Asian J Psychiatr; 2023 Apr; 82():103513. PubMed ID: 36827938
[TBL] [Abstract][Full Text] [Related]
27. The role of semantic clustering in the relationship between verbal memory and psychosocial functioning in schizophrenia and bipolar disorder: Possible distinct cognitive pathway compared to healthy controls.
Hasse-Sousa M; Martins DS; Petry-Perin C; Britto MJS; Remus IB; Lapa CO; Reckziegel RFX; Sales SC; Jesus LS; Philippsen M; Massuda R; Van Rheenen TE; Gama CS; Czepielewski LS
J Affect Disord; 2023 Jan; 320():330-339. PubMed ID: 36162669
[TBL] [Abstract][Full Text] [Related]
28. Schizotypal personality traits and social cognition are associated with childhood trauma exposure.
Quidé Y; Cohen-Woods S; O'Reilly N; Carr VJ; Elzinga BM; Green MJ
Br J Clin Psychol; 2018 Nov; 57(4):397-419. PubMed ID: 29923348
[TBL] [Abstract][Full Text] [Related]
29. Schizophrenia and Bipolar Polygenic Risk Scores in Relation to Intracranial Volume.
de Zwarte SMC; Brouwer RM; Kahn RS; van Haren NEM
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456501
[TBL] [Abstract][Full Text] [Related]
30. Reduced hippocampal gray matter volume is a common feature of patients with major depression, bipolar disorder, and schizophrenia spectrum disorders.
Brosch K; Stein F; Schmitt S; Pfarr JK; Ringwald KG; Thomas-Odenthal F; Meller T; Steinsträter O; Waltemate L; Lemke H; Meinert S; Winter A; Breuer F; Thiel K; Grotegerd D; Hahn T; Jansen A; Dannlowski U; Krug A; Nenadić I; Kircher T
Mol Psychiatry; 2022 Oct; 27(10):4234-4243. PubMed ID: 35840798
[TBL] [Abstract][Full Text] [Related]
31. Polygenic risk scores across the extended psychosis spectrum.
Smigielski L; Papiol S; Theodoridou A; Heekeren K; Gerstenberg M; Wotruba D; Buechler R; Hoffmann P; Herms S; Adorjan K; Anderson-Schmidt H; Budde M; Comes AL; Gade K; Heilbronner M; Heilbronner U; Kalman JL; Klöhn-Saghatolislam F; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Anghelescu IG; Arolt V; Baune BT; Dannlowski U; Dietrich DE; Fallgatter AJ; Figge C; Jäger M; Juckel G; Konrad C; Nieratschker V; Reimer J; Reininghaus E; Schmauß M; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Gryaznova A; Flatau-Nagel L; Reitt M; Meyers M; Emons B; Haußleiter IS; Lang FU; Becker T; Wigand ME; Witt SH; Degenhardt F; Forstner AJ; Rietschel M; Nöthen MM; Andlauer TFM; Rössler W; Walitza S; Falkai P; Schulze TG; Grünblatt E
Transl Psychiatry; 2021 Nov; 11(1):600. PubMed ID: 34836939
[TBL] [Abstract][Full Text] [Related]
32. Reduced Gray Matter Volume in Orbitofrontal Cortex Across Schizophrenia, Major Depressive Disorder, and Bipolar Disorder: A Comparative Imaging Study.
Yang Y; Li X; Cui Y; Liu K; Qu H; Lu Y; Li W; Zhang L; Zhang Y; Song J; Lv L
Front Neurosci; 2022; 16():919272. PubMed ID: 35757556
[TBL] [Abstract][Full Text] [Related]
33. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.
Chang M; Womer FY; Edmiston EK; Bai C; Zhou Q; Jiang X; Wei S; Wei Y; Ye Y; Huang H; He Y; Xu K; Tang Y; Wang F
Schizophr Bull; 2018 Jan; 44(1):65-74. PubMed ID: 29036668
[TBL] [Abstract][Full Text] [Related]
34. Mismatch negativity and polygenic risk scores for schizophrenia and bipolar disorder.
Pentz AB; O'Connel KS; van Jole O; Timpe CMF; Slapø NB; Melle I; Lagerberg TV; Steen NE; Westlye LT; Haukvik UK; Moberget T; Jönsson EG; Andreassen OA; Elvsåshagen T
Schizophr Res; 2024 Feb; 264():314-326. PubMed ID: 38215567
[TBL] [Abstract][Full Text] [Related]
35. Gray matter reduction in bilateral insula mediating adverse psychiatric effects of body mass index in schizophrenia.
Wu H; Dai G; Aizezi M; Tang J; Zou K; Wu Y; Wu X
BMC Psychiatry; 2022 Oct; 22(1):639. PubMed ID: 36221050
[TBL] [Abstract][Full Text] [Related]
36. Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases.
Charney AW; Stahl EA; Green EK; Chen CY; Moran JL; Chambert K; Belliveau RA; Forty L; Gordon-Smith K; Lee PH; Bromet EJ; Buckley PF; Escamilla MA; Fanous AH; Fochtmann LJ; Lehrer DS; Malaspina D; Marder SR; Morley CP; Nicolini H; Perkins DO; Rakofsky JJ; Rapaport MH; Medeiros H; Sobell JL; Backlund L; Bergen SE; Juréus A; Schalling M; Lichtenstein P; Knowles JA; Burdick KE; Jones I; Jones LA; Hultman CM; Perlis R; Purcell SM; McCarroll SA; Pato CN; Pato MT; Di Florio A; Craddock N; Landén M; Smoller JW; Ruderfer DM; Sklar P
Biol Psychiatry; 2019 Jul; 86(2):110-119. PubMed ID: 30686506
[TBL] [Abstract][Full Text] [Related]
37. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
[TBL] [Abstract][Full Text] [Related]
38. Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders.
Doan NT; Kaufmann T; Bettella F; Jørgensen KN; Brandt CL; Moberget T; Alnæs D; Douaud G; Duff E; Djurovic S; Melle I; Ueland T; Agartz I; Andreassen OA; Westlye LT
Neuroimage Clin; 2017; 15():719-731. PubMed ID: 28702349
[TBL] [Abstract][Full Text] [Related]
39. Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes.
Stein F; Meller T; Brosch K; Schmitt S; Ringwald K; Pfarr JK; Meinert S; Thiel K; Lemke H; Waltemate L; Grotegerd D; Opel N; Jansen A; Nenadić I; Dannlowski U; Krug A; Kircher T
Schizophr Bull; 2021 Oct; 47(6):1740-1750. PubMed ID: 33860786
[TBL] [Abstract][Full Text] [Related]
40. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.
Richards AL; Pardiñas AF; Frizzati A; Tansey KE; Lynham AJ; Holmans P; Legge SE; Savage JE; Agartz I; Andreassen OA; Blokland GAM; Corvin A; Cosgrove D; Degenhardt F; Djurovic S; Espeseth T; Ferraro L; Gayer-Anderson C; Giegling I; van Haren NE; Hartmann AM; Hubert JJ; Jönsson EG; Konte B; Lennertz L; Olde Loohuis LM; Melle I; Morgan C; Morris DW; Murray RM; Nyman H; Ophoff RA; ; van Os J; ; ; Petryshen TL; Quattrone D; Rietschel M; Rujescu D; Rutten BPF; Streit F; Strohmaier J; Sullivan PF; Sundet K; Wagner M; Escott-Price V; Owen MJ; Donohoe G; O'Donovan MC; Walters JTR
Schizophr Bull; 2020 Feb; 46(2):336-344. PubMed ID: 31206164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
